Total Payments
$180.81
2022 Payments
$43.40
Companies
4
Transactions
9
Medicare Patients
7,307
Medicare Billing
$680,835
Payment Breakdown by Category
Food & Beverage$137.41 (76.0%)
Education$43.40 (24.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $137.41 | 7 | 76.0% |
| Education | $43.40 | 2 | 24.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $54.49 | 4 | $0 (2017) |
| PFIZER INC. | $44.59 | 1 | $0 (2019) |
| Merck Sharp & Dohme LLC | $43.40 | 2 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $38.33 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $43.40 | 2 | Merck Sharp & Dohme LLC ($43.40) |
| 2019 | $44.59 | 1 | PFIZER INC. ($44.59) |
| 2018 | $38.33 | 2 | Boehringer Ingelheim Pharmaceuticals, Inc. ($38.33) |
| 2017 | $54.49 | 4 | Janssen Pharmaceuticals, Inc ($54.49) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/14/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Education | In-kind items and services | $21.70 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/29/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Education | In-kind items and services | $21.70 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/19/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $44.59 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/16/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: DIABETES | ||||||
| 03/16/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/08/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/01/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/17/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/04/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,272 | 1,462 | $427,501 | $115,999 |
| 2022 | 21 | 1,405 | 1,628 | $490,945 | $130,567 |
| 2021 | 17 | 2,308 | 3,073 | $765,626 | $236,248 |
| 2020 | 19 | 2,322 | 2,962 | $703,076 | $198,021 |
Total Patients
7,307
Total Services
9,125
Medicare Billing
$680,835
Procedure Codes
76
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 259 | 269 | $203,863 | $38,729 | 19.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 365 | 417 | $86,910 | $37,784 | 43.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 72 | 72 | $27,009 | $11,734 | 43.4% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 37 | 37 | $17,500 | $6,650 | 38.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 28 | 90 | $10,480 | $5,724 | 54.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 24 | 25 | $7,377 | $3,486 | 47.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $5,166 | $2,022 | 39.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 150 | 164 | $9,024 | $1,821 | 20.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 14 | $3,253 | $1,464 | 45.0% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 17 | 25 | $3,000 | $1,375 | 45.8% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 32 | 32 | $13,190 | $1,331 | 10.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 109 | 148 | $28,120 | $940.32 | 3.3% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 53 | 54 | $2,421 | $934.20 | 38.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 12 | $1,986 | $805.86 | 40.6% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 33 | 33 | $6,594 | $622.29 | 9.4% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 42 | 43 | $1,100 | $371.51 | 33.8% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 11 | 11 | $508.00 | $205.15 | 40.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 297 | 315 | $245,700 | $47,957 | 19.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 324 | 379 | $72,010 | $33,387 | 46.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 66 | 66 | $22,592 | $10,558 | 46.7% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2022 | 53 | 53 | $22,790 | $10,088 | 44.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 32 | 36 | $10,440 | $5,740 | 55.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 26 | 89 | $9,790 | $5,141 | 52.5% |
| 93280 | Programming of dual lead pacemaker system | Office | 2022 | 25 | 51 | $6,120 | $2,994 | 48.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 17 | $4,335 | $2,418 | 55.8% |
About Dr. William Levin, MD
Dr. William Levin, MD is a Cardiovascular Disease healthcare provider based in Smithfield, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1669470886.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Levin, MD has received a total of $180.81 in payments from pharmaceutical and medical device companies, with $43.40 received in 2022. These payments were reported across 9 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($137.41).
As a Medicare-enrolled provider, Levin has provided services to 7,307 Medicare beneficiaries, totaling 9,125 services with total Medicare billing of $680,835. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Smithfield, RI
- Active Since 07/12/2005
- Last Updated 02/22/2011
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1669470886
Products in Payments
- XARELTO (Drug) $54.49
- ELIQUIS (Drug) $44.59
- VERQUVO (Drug) $43.40
- JARDIANCE (Drug) $22.67
- PRADAXA (Drug) $15.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.